Trial intelligence / Profile preview

Viracept for MAC in AIDS Patients

NCT00002170Phase 2Completed

Sponsor
Agouron Pharmaceuticals
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nelfinavir in human immunodeficiency virus infection (HIV), sponsored by Agouron Pharmaceuticals. Status: completed.

02

Drugs

nelfinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00002170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call